Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript - Thomson StreetEvents

Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript

Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript - Thomson StreetEvents
Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript
Published Jan 29, 2021
Published Jan 29, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of REDY.NS earnings conference call or presentation 29-Jan-21 12:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Dr.Reddy's Laboratories Ltd
Ticker
REDY.NS
Time
12:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst : If I heard the number correctly, you said that excluding Wockhardt, our India business is growing about 8% in the quarter, which would imply that Wockhardt revenues are pretty much back to their peak sales level. Is that correct? And if that is the case, how should we look at momentum for Wockhardt from here? What will drive incremental growth or what you're indicating in line growth for Wockhardt from here?

Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst : And what will drive that growth? It is since most of the low-hanging fruit is already there in the numbers?

Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst : Okay. Understood. Okay. I'm not sure if I caught this in your opening remarks, but our working capital seemed to have increased in the quarter, both receivable and inventory. Could you indicate if there was anything specific here that you would like to point out?

Question: Neha Manpuria - JPMorgan Chase & Co, Research Division - Analyst : Understood. Okay. Fair enough. Just one other clarification on the U.S. business. The price erosion that we saw quarter-on-quarter, was that related to any specific product? And -- or was it across assets and across the portfolio, and that could probably continue?

Table Of Contents

Dr Reddy's Laboratories Ltd Q4 2022 Earnings Call Transcript – 2022-05-19 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 19-May-22 12:00pm GMT

Dr Reddy's Laboratories Ltd Q3 2022 Earnings Call Transcript – 2022-01-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Jan-22 1:00pm GMT

Dr Reddy's Laboratories Ltd Q2 2022 Earnings Call Transcript – 2021-10-29 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 29-Oct-21 12:00pm GMT

Dr Reddy's Laboratories Ltd Q1 2022 Earnings Call Transcript – 2021-07-27 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 27-Jul-21 12:00pm GMT

Dr.Reddy's Laboratories Ltd Q4 2021 Earnings Call Transcript – 2021-05-14 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 14-May-21 12:00pm GMT

Dr.Reddy's Laboratories Ltd at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-13 – US$ 54.00 – Edited Transcript of REDY.NS presentation 13-Jan-21 4:00pm GMT

Dr.Reddy's Laboratories Ltd Q2 2021 Earnings Call Transcript – 2020-10-28 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 28-Oct-20 12:00pm GMT

Dr.Reddy's Laboratories Ltd Q1 2021 Earnings Call Transcript – 2020-07-29 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 29-Jul-20 12:00pm GMT

Dr.Reddy's Laboratories Ltd Q4 2020 Earnings Call Transcript – 2020-05-20 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 20-May-20 11:45am GMT

Dr.Reddy's Laboratories Ltd Q3 2020 Earnings Call Transcript – 2020-01-27 – US$ 54.00 – Edited Transcript of REDY.NS earnings conference call or presentation 27-Jan-20 1:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript" Jan 29, 2021. Alacra Store. May 02, 2025. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-Dr-Reddy-s-Laboratories-Ltd-Earnings-Call-T13582114>
  
APA:
Thomson StreetEvents. (2021). Dr.Reddy's Laboratories Ltd Q3 2021 Earnings Call Transcript Jan 29, 2021. New York, NY: Alacra Store. Retrieved May 02, 2025 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q3-2021-Dr-Reddy-s-Laboratories-Ltd-Earnings-Call-T13582114>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.